Neuberger Berman Group
NUVB icon

Neuberger Berman Group’s Nuvation Bio NUVB Stock Holding History

Neuberger Berman Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Buy
18,820
+4,826
+34% +$23.6K ﹤0.01% 2238
2026
Q1 		$60K Sell
13,994
-4,380
-24% -$24.4K ﹤0.01% 2105
2025
Q4 		$165K Buy
18,374
+7,561
+70% +$46.8K ﹤0.01% 1982
2025
Q3 		$40K Buy
+10,813
New +$29.5K ﹤0.01% 2003
2025
Q2 		– Sell
-11,711
Closed -$20.6K – 2103
2025
Q1 		$20.6K Hold
11,711
– – ﹤0.01% 1936
2024
Q4 		$31.2K Buy
+11,711
New +$30.2K ﹤0.01% 1899

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Neuberger Berman Group's NUVB Position: Q2 2026 in Review

Neuberger Berman Group increased its Nuvation Bio (NUVB) stake by 34% in Q2 2026, buying an estimated $23.6K and bringing the position to 18,820 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2238.

Neuberger Berman Group first reported a position in NUVB in Q4 2024 and has held it in 6 quarters since. The position peaked at $165K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Neuberger Berman Group held 18,820 shares of Nuvation Bio worth $107K as of Q2 2026.
  • Neuberger Berman Group bought 4,826 Nuvation Bio shares in Q2 2026, an estimated $23.6K.
  • Nuvation Bio made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2238 holding.
  • Neuberger Berman Group first reported a position in Nuvation Bio in Q4 2024 and has held it in 6 quarters since.
  • Neuberger Berman Group's Nuvation Bio position peaked at $165K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.